BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 25820142)

  • 1. Erratum to: Mutations of HNRNPA0 and WIF1 predispose members of a large family to multiple cancers.
    Wei C; Peng B; Han Y; Chen WV; Rother J; Tomlinson GE; Richard Boland C; Chaussabel D; Frazier ML; Amos CI
    Fam Cancer; 2015 Jun; 14(2):307. PubMed ID: 25820142
    [No Abstract]   [Full Text] [Related]  

  • 2. Mutations of HNRNPA0 and WIF1 predispose members of a large family to multiple cancers.
    Wei C; Peng B; Han Y; Chen WV; Rother J; Tomlinson GE; Boland CR; Chaussabel D; Frazier ML; Amos CI
    Fam Cancer; 2015 Jun; 14(2):297-306. PubMed ID: 25716654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. WIF1, a component of the Wnt pathway, is down-regulated in prostate, breast, lung, and bladder cancer.
    Wissmann C; Wild PJ; Kaiser S; Roepcke S; Stoehr R; Woenckhaus M; Kristiansen G; Hsieh JC; Hofstaedter F; Hartmann A; Knuechel R; Rosenthal A; Pilarsky C
    J Pathol; 2003 Oct; 201(2):204-12. PubMed ID: 14517837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hereditary nonpolyposis colorectal cancer: diagnostic strategies and their implications.
    Bonis PA; Trikalinos TA; Chung M; Chew P; Ip S; DeVine DA; Lau J
    Evid Rep Technol Assess (Full Rep); 2007 May; (150):1-180. PubMed ID: 17764220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypermethylation of RUNX3 but not WIF1 gene and its association with stage and nodal status of tongue cancers.
    Supic G; Kozomara R; Jovic N; Zeljic K; Magic Z
    Oral Dis; 2011 Nov; 17(8):794-800. PubMed ID: 21819494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wnt inhibitory factor 1 induces apoptosis and inhibits cervical cancer growth, invasion and angiogenesis in vivo.
    Ramachandran I; Thavathiru E; Ramalingam S; Natarajan G; Mills WK; Benbrook DM; Zuna R; Lightfoot S; Reis A; Anant S; Queimado L
    Oncogene; 2012 May; 31(22):2725-37. PubMed ID: 22002305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and promoter methylation of Wnt inhibitory factor-1 in the development of oral submucous fibrosis.
    Zhou S; Chen L; Mashrah M; Zhu Y; He Z; Hu Y; Xiang T; Yao Z; Guo F; Zhang C
    Oncol Rep; 2015 Nov; 34(5):2636-42. PubMed ID: 26352791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression pattern of Wnt inhibitor factor 1(Wif1) during the development in mouse CNS.
    Hu YA; Gu X; Liu J; Yang Y; Yan Y; Zhao C
    Gene Expr Patterns; 2008 Sep; 8(7-8):515-22. PubMed ID: 18586116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roles of Wnt inhibitory factor 1 during tooth morphogenesis.
    Lee MJ; Kim EJ; Li L; Jung HS
    Cell Tissue Res; 2015 Oct; 362(1):61-8. PubMed ID: 25893927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical spectrum of homozygous and heterozygous PINK1 mutations in a large German family with Parkinson disease: role of a single hit?
    Hedrich K; Hagenah J; Djarmati A; Hiller A; Lohnau T; Lasek K; Grünewald A; Hilker R; Steinlechner S; Boston H; Kock N; Schneider-Gold C; Kress W; Siebner H; Binkofski F; Lencer R; Münchau A; Klein C
    Arch Neurol; 2006 Jun; 63(6):833-8. PubMed ID: 16769864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wnt inhibitory factor 1 (WIF1) is a marker of osteoblastic differentiation stage and is not silenced by DNA methylation in osteosarcoma.
    Baker EK; Taylor S; Gupte A; Chalk AM; Bhattacharya S; Green AC; Martin TJ; Strbenac D; Robinson MD; Purton LE; Walkley CR
    Bone; 2015 Apr; 73():223-32. PubMed ID: 25571841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adiponectin stimulates Wnt inhibitory factor-1 expression through epigenetic regulations involving the transcription factor specificity protein 1.
    Liu J; Lam JB; Chow KH; Xu A; Lam KS; Moon RT; Wang Y
    Carcinogenesis; 2008 Nov; 29(11):2195-202. PubMed ID: 18701434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. WIF1, an inhibitor of the Wnt pathway, is rearranged in salivary gland tumors.
    Queimado L; Lopes CS; Reis AM
    Genes Chromosomes Cancer; 2007 Mar; 46(3):215-25. PubMed ID: 17171686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inactivation of Wnt inhibitory factor-1 (WIF1) expression by epigenetic silencing is a common event in breast cancer.
    Ai L; Tao Q; Zhong S; Fields CR; Kim WJ; Lee MW; Cui Y; Brown KD; Robertson KD
    Carcinogenesis; 2006 Jul; 27(7):1341-8. PubMed ID: 16501252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of Wnt signaling inhibits angiogenesis and tumor growth in hepatocellular carcinoma.
    Hu J; Dong A; Fernandez-Ruiz V; Shan J; Kawa M; Martínez-Ansó E; Prieto J; Qian C
    Cancer Res; 2009 Sep; 69(17):6951-9. PubMed ID: 19690140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Germ-line p53 mutations predispose to a wide spectrum of early-onset cancers.
    Nichols KE; Malkin D; Garber JE; Fraumeni JF; Li FP
    Cancer Epidemiol Biomarkers Prev; 2001 Feb; 10(2):83-7. PubMed ID: 11219776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysregulation of Wnt pathway components in human salivary gland tumors.
    Queimado L; Obeso D; Hatfield MD; Yang Y; Thompson DM; Reis AM
    Arch Otolaryngol Head Neck Surg; 2008 Jan; 134(1):94-101. PubMed ID: 18209144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of R337H, a germline TP53 mutation predisposing to multiple cancers, in asymptomatic women participating in a breast cancer screening program in Southern Brazil.
    Palmero EI; Schüler-Faccini L; Caleffi M; Achatz MI; Olivier M; Martel-Planche G; Marcel V; Aguiar E; Giacomazzi J; Ewald IP; Giugliani R; Hainaut P; Ashton-Prolla P
    Cancer Lett; 2008 Mar; 261(1):21-5. PubMed ID: 18248785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sporadic mutations of the p53 gene in multiple myeloma and no evidence for germline mutations in three familial multiple myeloma pedigrees.
    Willems PM; Kuypers AW; Meijerink JP; Holdrinet RS; Mensink EJ
    Leukemia; 1993 Jul; 7(7):986-91. PubMed ID: 8321049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple primary cancers as a guide to heritability.
    Cybulski C; Nazarali S; Narod SA
    Int J Cancer; 2014 Oct; 135(8):1756-63. PubMed ID: 24945890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.